Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (131-140 of 443) with videos related to

Pageof 45
Sort By:
Journal of Hematology & Oncology|March 17, 2018
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMTAnnalisa Ruggeri, Myriam Labopin, Andrea Bacigalupo, et al.
Leukemia Research|May 25, 2015
Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationMohamed A Kharfan-Dabaja, Myriam Labopin, Ali Bazarbachi, et al.
Cancer|March 19, 2021
Outcome of T-cell-replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Yener Koc, et al.
Haematologica|May 4, 2019
Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMTXavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Cancer|April 1, 2018
Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the EBMTTomasz Czerw, Myriam Labopin, Sebastian Giebel, et al.
Journal of Hematology & Oncology|August 5, 2016
The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working partyMarie T Rubio, Bipin N Savani, Myriam Labopin, et al.
Bone Marrow Transplantation|April 24, 2025
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in active disease: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSara Tarantino, Myriam Labopin, Robert Zeiser, et al.
Bone Marrow Transplantation|June 1, 2021
A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT studyMohamad Mohty, Marta Lisa Battista, Didier Blaise, et al.
Bone Marrow Transplantation|August 18, 2023
Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantationRémy Duléry, Florent Malard, Eolia Brissot, et al.
Bone Marrow Transplantation|September 27, 2019
Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemiaPierre-Edouard Debureaux, Myriam Labopin, Anne-Claire Mamez, et al.
Pageof 45

Showing results (131-140 of 443) with videos related to

Sort By:
Pageof 45
Journal of Hematology & Oncology|March 17, 2018
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMTAnnalisa Ruggeri, Myriam Labopin, Andrea Bacigalupo, et al.
Leukemia Research|May 25, 2015
Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationMohamed A Kharfan-Dabaja, Myriam Labopin, Ali Bazarbachi, et al.
Cancer|March 19, 2021
Outcome of T-cell-replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Yener Koc, et al.
Haematologica|May 4, 2019
Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMTXavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Cancer|April 1, 2018
Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the EBMTTomasz Czerw, Myriam Labopin, Sebastian Giebel, et al.
Journal of Hematology & Oncology|August 5, 2016
The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working partyMarie T Rubio, Bipin N Savani, Myriam Labopin, et al.
Bone Marrow Transplantation|April 24, 2025
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in active disease: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSara Tarantino, Myriam Labopin, Robert Zeiser, et al.
Bone Marrow Transplantation|June 1, 2021
A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT studyMohamad Mohty, Marta Lisa Battista, Didier Blaise, et al.
Bone Marrow Transplantation|August 18, 2023
Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantationRémy Duléry, Florent Malard, Eolia Brissot, et al.
Bone Marrow Transplantation|September 27, 2019
Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemiaPierre-Edouard Debureaux, Myriam Labopin, Anne-Claire Mamez, et al.
Pageof 45